10 December 2020: Clinical Research
Repeat Administration of Bone Marrow-Derived Mesenchymal Stem Cells for Treatment of Amyotrophic Lateral Sclerosis
Tomasz Siwek 12ABDEFG* , Katarzyna Jezierska-Woźniak 3ABDEF , Stanisław Maksymowicz 4BCDEF , Monika Barczewska 56BD , Mariusz Sowa 56B , Wanda Badowska 7B , Wojciech Maksymowicz 56ADGDOI: 10.12659/MSM.927484
Med Sci Monit 2020; 26:e927484
Figure 3 The monthly change in the total Revised Amyotrophic Lateral Sclerosis Functional Rating Scale scores before and during treatment, and the linear trend function for the treatment period, based on data from the pretreatment observation period. The rate of progression was unchanged. (Arrows indicate injections.)